TEGRETOL 20 mg/ml, oral suspension bottle, 150 ml
Brand page: Tegretol (carbamazepine) — all forms and strengths in France
Active ingredients: Carbamazepin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Oral suspensionbottle, 150 mlorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- TEGRETOL 20 mg/ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 150 ml avec seringue(s) pour administration orale
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1992
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65608566CIP73295639CIP133400932956395Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBAMAZÉPINEsuspension | 2 g · 100 ml de suspension buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.